AURP Announces New CEO and Launches ‘AURP HQ2’ in Washington, DC Area

Published on :

AURP Announces New CEO and Launches ‘AURP HQ2’ in Washington, DC Area Tucson, AZ, and College Park, MD, Feb. 7, 2019 – The Association of University Research Parks (AURP), a professional association of university-related research and science parks, announced the appointment of Brian Darmody, Associate Vice President of Corporate Engagement at the University of Maryland [….]

Smithers Avanza Toxicology Services Adds Lyric Boyle As Director, Business Development

Published on :

Smithers Avanza Toxicology Services Adds Lyric Boyle As Director, Business Development ••• GAITHERSBURG, MD, USA – January 30, 2019 – Smithers Avanza Toxicology Services, a boutique contract research organization (CRO) specializing in general toxicology, vaccine safety and developmental and reproductive toxicology (DART), recently appointed Ms. Lyric Boyle as Director, Business Development. The addition supports the organization’s commitment [….]

UMB’s Microbial Genomics Trailblazer Claire M. Fraser Named AAAS President-Elect

Published on :

UMB’s Microbial Genomics Trailblazer Claire M. Fraser Named AAAS President-Elect Claire M. Fraser will become the next president-elect of AAAS in February. | Tom Jemski/University of Maryland School of Medicine Claire M. Fraser, director and founder of the University of Maryland School of Medicine’s Institute for Genome Sciences and a pioneer in the field of [….]

Emergent BioSolutions Announces Daniel J. Abdun-Nabi to Retire As CEO; Robert G. Kramer, Sr. To Become President and CEO

Published on :

GAITHERSBURG, Md., Jan. 04, 2019 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced that its CEO Daniel J. Abdun-Nabi will be retiring and that its board of directors has unanimously appointed Robert G. Kramer, Sr., the company’s current president and COO, to succeed him as president and CEO, effective April 1, 2019. Mr. [….]

MedImmune CEO Bahija Jallal Departs for Chief Executive Officer Appointment at Immunocore

Published on :

MedImmune CEO Bahija Jallal Departs for Chief Executive Officer Appointment at Immunocore OXFORD, England and CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announces that Bahija Jallal has been appointed as Chief Executive Officer and Director of the Board. “I am excited to have the opportunity to head Immunocore, the [….]

NexImmune Completes Sr. Leadership Team With New VP Hires

Published on :

NexImmune Completes Sr. Leadership Team With New VP Hires Naimish Pandya, MD assumes role of VP & Head, Clinical Development Alex Matschiner, MS ChE assumes role of VP, Protein Process Development GAITHERSBURG, Md., Dec. 04, 2018 (GLOBE NEWSWIRE) — NexImmune, an emerging leader in the field of antigen-directed immunotherapy, today announced the hiring of two [….]

ABL, Inc. Announces Hiring of Jarlath Keating As Chief Commercial Officer

Published on :

ABL, Inc. Announces Hiring of Jarlath Keating As Chief Commercial Officer September 26, 2018 (Rockville, MD) – ABL, Inc. (ABL), a leading global contract research and manufacturing service provider to the biopharmaceutical industry, announces the hire of Jarlath Keating as Chief Commercial Officer (CCO). As CCO, Mr. Keating will report to the Chief Executive Officer (CEO) [….]

Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team As Chief Technology Officer

Published on :

Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team As Chief Technology Officer Gaithersburg, MD, United States, September 25, 2018 — Sirnaomics, Inc., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that Dmitry Samarsky, Ph.D., will be joining the company’s senior management team as Chief Technology Officer, taking effect on October [….]

Paragon Bioservices Fills Key Leadership Position with New CFO Hire

Published on :

Paragon Bioservices Fills Key Leadership Position with New CFO Hire Seasoned Executive Gerard Fleury Joins the Company as Chief Financial Officer BALTIMORE, June 6, 2018 /PRNewswire/ — Paragon Bioservices, the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, announces today that it filled a key leadership position [….]

ABL, Inc. Announces Hiring of Marykay Marchigiani As Chief Financial Officer

Published on :

ABL, Inc. Announces Hiring of Marykay Marchigiani As Chief Financial Officer June 4, 2018 (Rockville, MD) – ABL, Inc. (ABL) a leading global contract research and manufacturing service provider to the biopharmaceutical industry announces the hire of Marykay Marchigiani as Chief Financial Officer (CFO).  As CFO, Ms. Marchigiani will report to the Chief Executive Officer (CEO) [….]